Skip to main content
Equibles

North Star Investment Management Corp.

Position in EXEL — Exelixis, Inc.

CIK 1342857 CHICAGO, IL
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$68,556
+$14,515 QoQ
Shares Held
1,260
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#612
of 756 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

North Star Investment Management Corp. holds $1,330,782 across 45 Biotechnology names. EXEL ranks #5 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 8,571 $403,179
2 TGTX
Tg Therapeutics, Inc.
 3,900 $214,266
3 ATAI
AtaiBeckley Inc.
 38,375 $202,236
4 VKTX
Viking Therapeutics, Inc.
 3,058 $119,292
5 EXEL
Exelixis, Inc.
This page 		1,260 $68,556
6 ALT
Altimmune, Inc.
 22,000 $66,880
7 GHRS
GH Research PLC
 2,200 $59,136
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 65 $32,287

All Filings in EXEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,556 1,260
2026-03-31 $54,041 1,260
2025-12-31 $55,225 1,260
2025-09-30 $52,038 1,260
2025-06-30 $55,540 1,260
2025-03-31 $46,519 1,260
2024-12-31 $41,958 1,260
2024-09-30 $1,557 60
2024-06-30 $1,348 60
2024-03-31 $1,423 60
2023-12-31 $1,439 60
2023-09-30 $1,311 60
2023-06-30 $1,146 60
2023-03-31 $1,164 60
2022-12-31 $962 60
2022-09-30 $940 60
2022-06-30 $1,249 60
2022-03-31 $1,360 60
2021-12-31 $1,096 60
2021-09-30 $1,268 60
2021-06-30 $1,093 60
2021-03-31 $1,355 60
2020-12-31 $1,204 60
2020-09-30 $953 39